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H of cytokines. In hematologic malignancies, such cytokines could operate as autocrine growth factors that would play an important role in the autonomous growth of malignant cells. Cytokines have previously been reported to be autocrine growth factors for acute myeloid leukemia (AML) cells: interleukin-1 (IL-I), IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), and macrophage-CSF (M-CSF).1-5 Furthermore, IL-6 has been reported as an autocrine growth factor in multiple myeloma,6 whereas chronic myelomonocytic leukemia (CMMoL) cells showed autocrine growth on stimulation with IL-6 and GM-CSF. 7 With regards to normal megakaryocytopoiesis, IL-3, IL-6, GM-CSF, and leukemia inhibitory factor (LIF) have been reported to stimulate megakaryocyte progenitors and platelet production both in vitro and in vivo.8- 16 Another cytokine, recombinant human IL-1 1 (rhIL-1 I), has recently been cloned from a human lung fibroblast cell line, MRC5.I' We have recently reported that this cytokine stimulates normal human megakaryocytopoiesis in vitro." We have also observed that administration of rhIL 11 to normal mice resulted in a 1.5-fold increase in platelet numbers (manuscript in preparation). In malignant states of megakaryocytic lineage, IL-6 has been reported as a possible autocrine growth factor for CMK cells and megakaryoblastic leukemia cell^.'^-^^ In this study, we investigated the effects of IL-1 1 on a human megakaryoblastic cell line, CMK, and a recently established megakaryoblastic cell line, Meg-J. We showed that IL-1 1 was an autocrine growth factor for the megakaryocytic leukemic cells. This is the first report to show that IL-I 1 acts as an autocrine growth factor in the hematopoietic cells.
MATERIALS AND METHODS
Cells and culture. The human megakaryoblastic cell line, CMK, was established from a Down's syndrome patient with acute megakaryoblastic Meg-J was established in our laboratory from the patient with chronic myeloid leukemia and blastic crisis. The Meg-J had characteristics of megakaryocytes. The Meg-J cells were positive for the platelet-associated glycoprotein (GP) IIb/IIIa, GP Ib, and positive for platelet peroxidase (PPO) (manuscript in preparation). Other leukemia cell lines, HL-60, U937, and K562, were also used for this study. Cells were maintained in RPMI 1640 medium (RPMI 1640; Flow Laboratories, Irvine, UK) containing 10% heat-inactivated fetal calf serum (FCS) at 37°C in a humidified using a reverse transcriptase-polymerase chain reaction assay. These findings indicate that IL-1 1 might be an autocrine growth factor for megakaryoblastic cells. I L -I 1 transcripts also existed in other leukemia cell lines: HL-60, U937, and K562. However, the growth of these cells was not stimulated by IL-I 1, and was not inhibited by IL-1 1 antisense oligonucleotides. These results suggested that IL-1 1 might regulate malignant cells of the megakaryocytic lineage, in part by an autocrine loop.
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atmosphere of 5% CO2 in air. To analyze the surface antigens, cells were stimulated with phorbol-12-myristate-13-acetate (PMA; Sigma, St Louis, MO) at a concentration of 10 ng/mL, at 37°C in a 5% CO2 humidified atmosphere for 24 hours. To investigate the effect of IL-I I sense and antisense oligonucleotides on the expression of IL-11 mRNA, CMK cells were incubated in RPMI containing 2.5% FCS with 5 pmol/L IL-I 1 sense or antisense oligonucleotides for 24 hours. Cells were washed with phosphate-buffered saline (PBS) for three times.
rhIL-1 I and rabbit polyclonal anti-IL-11 antibody (IgG) were provided by the Genetics Institute (Cambridge, MA). The specific activity of rhIL-I1 was 2 X IO6 U/ mg. Five micrograms per milliliter of anti-IL-1 1 antibody neutralized 0.57 ng/mL of IL-11. The rhIL-6 and anti-IL-6 antibody were provided by Ajinomoto (Kanagawa, Japan). The specific activity of rhIL-6 was 6 X IO6 U/mg protein; 1 pg/mL anti-IL-6 antibody neutralized 1 ng/mL of IL-6. Rabbit polyclonal IgG (Zymed, San Francisco, CA) was used as a control antibody.
A I 5-base antisense oligonucleotide (GCAAACACAGTTCAT) was prepared (Cyclone; Milligen, Tokyo, Japan). A control sense oligonucleotide was used in each experiment. Cells (5 X IO') were cultured for 48 hours in 100 pL RPMI 1640 supplemented with 2.5% FCS in 96-microwell plates (Flow Laboratories Inc) in the presence of cytokines, antibodies, and oligonucleotides at 37°C in a fully humidified incubator at 5% CO2. One microcurie per well of 'H-thymidine (6.7 Ci mmol-l; New England Nuclear, Boston, MA) was added for the last 6 hours of incubation. The cells were harvested on glass-fiber filters, using an automatic cell harvester, and the radioactivity was measured using a liquid scintillation counter. 
Growth factors and antibodies.
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PCR amplification, using a Perkin-Elmer Cetus thermal cycler for 30 cycles. Cycling conditions were: denaturation at 94°C for 1 minute, annealing at 55°C for 5 minutes, and extension at 72°C for 5 minutes. Ethidium bromide-stained 2% agarose gels were used to separate PCR fragments.
The expression of platelet-specific antigens was examined by using monoclonal antibodies against GP Ib (SZ6; Cosmobio, Tokyo, Japan) and GP IIb/IIIa (P2; Cosmobio) and by indirect immunofluorescence assay. Briefly, cells were incu- DNA quantitation. Staining and cell DNA quantitation were performed with DAPl (4',6-diamidino-2-phenylindole) staining as described previously.8,9
Detection of siirjhce antigens. Sfufisficd unu/wis. Statistical analysis of differences was performed with the Student's !-test. Ploidy distributions were compared by using the Pearson's test for the independence of distributions. cell lines (Fig 4) . To determine whether this growth stimulation produced by IL-I I was due to the induction of IL-6, a known possible autocrine growth factor for CMK cells, we examined the effects of anti-IL-6 antibodies on the growth of IL-1 I-stimulated CMK cells. The growth stimulation produced by IL-I 1 was not affected by the addition of anti-IL-6 antibody (Fig 2B) .
RESULTS
The effects of IL-
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To determine whether megakaryoblastic cells produced IL-1 1 and proliferated via an IL-I 1 autocrine loop, we investigated the expression of IL-1 I mRNA using reverse transcriptase-PCR (RT-PCR) amplification with specific IL-1 I primers. As shown in Fig 5A, RT-PCR analysis showed IL-I 1 mRNA to be present in CMK and Meg-J cells. IL-11 transcripts also existed in acute leukemia cell lines: HL-60, U937, and K562 (Fig 5B) . IL-I 1 transcript was not detected in CMK cells incubated with IL-1 I antisense oligonucleotides; by contrast, the expression of j32-microglobulin was detectable in the antisense-treated cells (Fig 5C) .
Effect qf IL-1 I on megakaryoblastic cell differentiation. The effects of IL-I 1 on the megakaryocytic differentiation of cells were investigated (Table I ). The expression of GP Ib and GPIIb/IIIa was not changed after culture with IL-I 1 at either the concentration of I O ng/mL or that of 100 ng/mL, whereas the expression of GP Ib and GPIIb/IIIa was increased by more than 95% in cells stimulated with PMA, as reported previously.2o IL-1 I did not change the ploidy of cells (data not shown).
IL-11 mRNA expression in leukemia cells.
DISCUSSION
In this study, we examined the effects of IL-11 on megakaryoblastic cell lines, CMK and Meg-J. The growth of these cells was stimulated by IL-1 1 and inhibited by IL-1 I antisense oligonucleotides. The presence of IL-1 1 transcripts in the cell was detected via RT-PCR assay. IL-11 treatment did not alter the surface expression of platelet GP IIb/IIIa and GP Ib nor ploidy distribution. These findings suggest that IL-I 1 acts as an autocrine growth factor for CMK and Meg-J cells. However, it is not necessarily true that IL-I 1 is the only autocrine growth factor that can act on these cell lines. Previously, IL-6 has been suggested to be an autocrine growth factor for CMK." Another study has shown that stem cell factor (SCF) stimulated the proliferation of CMK cells and also induced the mRNA of various cytokines, including IL-6, in CMK cells.24 Therefore, it is possible that IL-11 upregulates the growth of CMK cells via the stimulation of IL-6 production in CMK cells. However, our present finding that anti-IL-6 antibody did not suppress the effect of IL-11 on CMK cells suggested that the effect of IL-11 on these cells is unlikely to be mediated by IL-6. However, it is possible that the synthesis of IL-6 might be stimulated by IL-I 1 without secretion of IL-6 into the supernatant. IL-I I transcripts were detected in the acute leukemia cell lines HL-60, U937, and K562. However, the growth of these cell lines was not stimulated by IL-1 I, nor was it inhibited by IL-1 1 antisense oligonucleotides. This shows that IL-I 1 does not play an important role in the proliferation of these cells. Furthermore, it might be possible to speculate that IL-I 1 might stimulate the growth of only the leukemic cells with a megakaryocytic feature. Whether such a growth mechanism is also present in freshly isolated leukemia cells remains to be determined.
IL-11 is known to have physiologic actions that overlap those of IL-6, eg, 1L-11 acts synergistically with IL-3 in shortening the Go period of hematopoietic progenitor cells, promotes megakaryocytopoiesis with IL-3 in vitro, and stimulates the synthesis of acute inflammatory protein^.'^.^^ In hematologic disorders, IL-6 has been reported to operate as an autocrine growth factor for AML, CMMoL, and myeloma cells. Therefore, it is possible to speculate that IL-I 1, like IL-6, acts as an autocrine growth factor in some hematologic malignancies. However in multiple myeloma, IL-I 1 has no stimulatory effect on the proliferation of freshly isolated human myeloma cells or derived cell lines, and the myeloma cells do not express IL-1 1 transcripts, protein, or recept01-s.~'
These findings indicate that, in a hematologic malignancy, the role of IL-1 1 is different from that of IL-6. In conclusion, the present finding that IL-11 acts as an autocrine growth factor in megakaryoblastic cells suggests that IL-I 1 regulates the proliferation of malignant cells of megakaryocytic lineage, in part, by an autocrine loop. Further studies are necessary to clarify whether this is true for normal megakaryocytes as well as for leukemic cells. 
